Cambrex, a global contract development and manufacturing organization, agreed to acquire Q1 Scientific, a provider of environmentally-controlled cGMP stability storage services for the pharmaceutical, medical device and life science industries. Financial terms were not disclosed. "We’re pleased to join Cambrex as we continue to provide leading stability storage services to our current customers. With Cambrex’s scientific expertise and scale, we’ll be able to accelerate our growth and offer an integrated suite of analytical services, providing a full range of market-leading solutions for our customers," Stephen Delaney, Q1 Scientific CEO.